• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病患者慢性支气管感染的当前挑战

Current Challenges in Chronic Bronchial Infection in Patients with Chronic Obstructive Pulmonary Disease.

作者信息

Lopez-Campos José Luis, Miravitlles Marc, de la Rosa Carrillo David, Cantón Rafael, Soler-Cataluña Juan Jose, Martinez-Garcia Miguel Angel

机构信息

Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/Universidad de Sevilla, 41013 Seville, Spain.

CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, 28029 Madrid, Spain.

出版信息

J Clin Med. 2020 May 28;9(6):1639. doi: 10.3390/jcm9061639.

DOI:10.3390/jcm9061639
PMID:32481769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7356662/
Abstract

Currently, chronic obstructive pulmonary disease (COPD) patients and their physicians face a number of significant clinical challenges, one of which is the high degree of uncertainty related to chronic bronchial infection (CBI). By reviewing the current literature, several challenges can be identified, which should be considered as goals for research. One of these is to establish the bases for identifying the biological and clinical implications of the presence of potentially pathogenic microorganisms in the airways that should be more clearly elucidated according to the COPD phenotype. Another urgent area of research is the role of long-term preventive antibiotics. Clinical trials need to be carried out with inhaled antibiotic therapy to help clarify the profile of those antibiotics. The role of inhaled corticosteroids in patients with COPD and CBI needs to be studied to instruct the clinical management of these patients. Finally, it should be explored and confirmed whether a suitable antimicrobial treatment during exacerbations may contribute to breaking the vicious circle of CBI in COPD. The present review addresses the current state of the art in these areas to provide evidence which will enable us to progressively plan better healthcare for these patients.

摘要

目前,慢性阻塞性肺疾病(COPD)患者及其医生面临着一些重大的临床挑战,其中之一是与慢性支气管感染(CBI)相关的高度不确定性。通过回顾当前文献,可以确定几个挑战,这些挑战应被视为研究目标。其中之一是建立识别气道中潜在致病微生物存在的生物学和临床意义的基础,应根据COPD表型更清楚地阐明这些意义。另一个紧迫的研究领域是长期预防性抗生素的作用。需要进行吸入抗生素治疗的临床试验,以帮助明确这些抗生素的情况。需要研究吸入性糖皮质激素在COPD和CBI患者中的作用,以指导这些患者的临床管理。最后,应探索并确认在急性加重期进行适当的抗菌治疗是否有助于打破COPD中CBI的恶性循环。本综述阐述了这些领域的当前技术水平,以提供证据,使我们能够逐步为这些患者规划更好的医疗保健。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dd8/7356662/9ae94b17b321/jcm-09-01639-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dd8/7356662/bb20e16f6d51/jcm-09-01639-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dd8/7356662/9ae94b17b321/jcm-09-01639-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dd8/7356662/bb20e16f6d51/jcm-09-01639-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dd8/7356662/9ae94b17b321/jcm-09-01639-g002.jpg

相似文献

1
Current Challenges in Chronic Bronchial Infection in Patients with Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者慢性支气管感染的当前挑战
J Clin Med. 2020 May 28;9(6):1639. doi: 10.3390/jcm9061639.
2
Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study.吸入性抗生素治疗慢性阻塞性肺疾病患者的有效性和安全性。一项多中心观察性研究。
Arch Bronconeumol. 2022 Jan;58(1):11-21. doi: 10.1016/j.arbres.2021.03.009. Epub 2021 Mar 19.
3
[Chronic Bronchial Infection in Stable COPD].[稳定期慢性阻塞性肺疾病中的慢性支气管感染]
Open Respir Arch. 2023 Feb 3;5(1):100234. doi: 10.1016/j.opresp.2023.100234. eCollection 2023 Jan-Mar.
4
Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.低剂量茶碱口服联合吸入皮质激素治疗慢性阻塞性肺疾病且有加重高风险的患者:一项 RCT 研究。
Health Technol Assess. 2019 Jul;23(37):1-146. doi: 10.3310/hta23370.
5
Inhaled Steroids, Circulating Eosinophils, Chronic Airway Infection, and Pneumonia Risk in Chronic Obstructive Pulmonary Disease. A Network Analysis.吸入性类固醇、循环嗜酸性粒细胞、慢性气道感染与慢性阻塞性肺疾病肺炎风险:网络分析。
Am J Respir Crit Care Med. 2020 May 1;201(9):1078-1085. doi: 10.1164/rccm.201908-1550OC.
6
[Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].[中国专家共识声明:囊性纤维化的诊断与治疗(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2023 Apr 12;46(4):352-372. doi: 10.3760/cma.j.cn112147-20221214-00971.
7
Bronchial hyper-responsiveness and exhaled nitric oxide in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的支气管高反应性与呼出一氧化氮
Swiss Med Wkly. 2007 Jul 14;137(27-28):385-91. doi: 10.4414/smw.2007.11677.
8
Chronic bronchial infection and incident cardiovascular events in chronic obstructive pulmonary disease patients: A long-term observational study.慢性支气管感染与慢性阻塞性肺疾病患者心血管事件的发生:一项长期观察性研究。
Respirology. 2021 Aug;26(8):776-785. doi: 10.1111/resp.14086. Epub 2021 May 18.
9
Chronic Bronchial Infection Is Associated with More Rapid Lung Function Decline in Chronic Obstructive Pulmonary Disease.慢性支气管感染与慢性阻塞性肺疾病肺功能下降速度加快有关。
Ann Am Thorac Soc. 2022 Nov;19(11):1842-1847. doi: 10.1513/AnnalsATS.202108-974OC.
10
Inhaled corticosteroids for stable chronic obstructive pulmonary disease.吸入性糖皮质激素用于稳定期慢性阻塞性肺疾病
Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD002991. doi: 10.1002/14651858.CD002991.pub3.

引用本文的文献

1
Characteristics and actions in high-risk COPD in unstable patients: The EPOCONSUL audit.不稳定患者中高危慢性阻塞性肺疾病(COPD)的特征与行为:EPOCONSUL审计
PLoS One. 2025 Jul 18;20(7):e0327775. doi: 10.1371/journal.pone.0327775. eCollection 2025.
2
Tolerance and effectiveness of inhaled antibiotics at standard or low doses in COPD patients with chronic Pseudomonas aeruginosa bronchial infection.标准剂量或低剂量吸入性抗生素对慢性铜绿假单胞菌支气管感染的慢性阻塞性肺疾病(COPD)患者的耐受性和有效性。
Sci Rep. 2025 Mar 13;15(1):8773. doi: 10.1038/s41598-025-91763-w.
3
Interplay between Lung Diseases and Viral Infections: A Comprehensive Review.

本文引用的文献

1
Consensus Document on the Diagnosis and Treatment of Chronic Bronchial Infection in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病慢性支气管感染诊断与治疗的共识文件。
Arch Bronconeumol (Engl Ed). 2020 Oct;56(10):651-664. doi: 10.1016/j.arbres.2020.04.023. Epub 2020 Jun 13.
2
Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病临床试验中的血液嗜酸性粒细胞计数
Am J Respir Crit Care Med. 2020 Sep 1;202(5):660-671. doi: 10.1164/rccm.201912-2384PP.
3
Clinical Management of COPD in a Real-World Setting. A Big Data Analysis.
肺部疾病与病毒感染之间的相互作用:综述
Microorganisms. 2024 Oct 8;12(10):2030. doi: 10.3390/microorganisms12102030.
4
A comprehensive review of infection in chronic lung diseases: recent advances in understanding asthma, COPD, and bronchiectasis.慢性肺部疾病感染综合综述:哮喘、慢性阻塞性肺疾病和支气管扩张症认识的最新进展
Front Med (Lausanne). 2024 Sep 25;11:1437731. doi: 10.3389/fmed.2024.1437731. eCollection 2024.
5
Microbiological Monitoring in Therapeutic Trials in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病治疗试验中的微生物监测
Am J Respir Crit Care Med. 2023 Nov 15;208(10):1142-1143. doi: 10.1164/rccm.202307-1214LE.
6
Isolation of in Stable Chronic Obstructive Pulmonary Disease Patients-Should We Treat It?稳定期慢性阻塞性肺疾病患者的隔离——我们应该治疗吗?
J Clin Med. 2023 Aug 1;12(15):5054. doi: 10.3390/jcm12155054.
7
[Chronic Bronchial Infection in Stable COPD].[稳定期慢性阻塞性肺疾病中的慢性支气管感染]
Open Respir Arch. 2023 Feb 3;5(1):100234. doi: 10.1016/j.opresp.2023.100234. eCollection 2023 Jan-Mar.
8
The Impact of Chronic Bronchial Infection in COPD: A Proposal for Management.慢性支气管感染对 COPD 的影响:管理建议。
Int J Chron Obstruct Pulmon Dis. 2022 Mar 23;17:621-630. doi: 10.2147/COPD.S357491. eCollection 2022.
9
Long-Term Risk of Mortality Associated with Isolation of in COPD: A Systematic Review and Meta-Analysis.慢性阻塞性肺疾病中分离出 与长期死亡率相关的风险:系统评价和荟萃分析。
Int J Chron Obstruct Pulmon Dis. 2022 Feb 16;17:371-382. doi: 10.2147/COPD.S346294. eCollection 2022.
10
Decalogue for the selection of oral antibiotics for lower respiratory tract infections.下呼吸道感染口服抗生素选择的十项准则。
Rev Esp Quimioter. 2022 Feb;35(1):16-29. doi: 10.37201/req/172.2021. Epub 2022 Jan 19.
真实世界中 COPD 的临床管理。大数据分析。
Arch Bronconeumol (Engl Ed). 2021 Feb;57(2):94-100. doi: 10.1016/j.arbres.2019.12.025. Epub 2020 Feb 22.
4
Impact of Isolation on Mortality and Outcomes in an Outpatient Chronic Obstructive Pulmonary Disease Cohort.隔离对门诊慢性阻塞性肺疾病队列患者死亡率及预后的影响
Open Forum Infect Dis. 2020 Jan 4;7(1):ofz546. doi: 10.1093/ofid/ofz546. eCollection 2020 Jan.
5
Bronchial Infection and Temporal Evolution of Bronchiectasis in Patients With Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者的支气管感染和支气管扩张的时间演变。
Clin Infect Dis. 2021 Feb 1;72(3):403-410. doi: 10.1093/cid/ciaa069.
6
Long-term impact of inhaled corticosteroid use in asthma and chronic obstructive pulmonary disease (COPD): Review of mechanisms that underlie risks.吸入性糖皮质激素在哮喘和慢性阻塞性肺疾病(COPD)中的长期影响:潜在风险机制综述
J Allergy Clin Immunol. 2020 Dec;146(6):1292-1294. doi: 10.1016/j.jaci.2019.12.907. Epub 2020 Jan 14.
7
Inhaled Steroids, Circulating Eosinophils, Chronic Airway Infection, and Pneumonia Risk in Chronic Obstructive Pulmonary Disease. A Network Analysis.吸入性类固醇、循环嗜酸性粒细胞、慢性气道感染与慢性阻塞性肺疾病肺炎风险:网络分析。
Am J Respir Crit Care Med. 2020 May 1;201(9):1078-1085. doi: 10.1164/rccm.201908-1550OC.
8
Low penetrance of antibiotics in the epithelial lining fluid. The role of inhaled antibiotics in patients with bronchiectasis.上皮衬液中抗生素的低渗透性。吸入抗生素在支气管扩张症患者中的作用。
Pulm Pharmacol Ther. 2020 Feb;60:101885. doi: 10.1016/j.pupt.2019.101885. Epub 2019 Dec 28.
9
Nebulized Colistin And Continuous Cyclic Azithromycin In Severe COPD Patients With Chronic Bronchial Infection Due To : A Retrospective Cohort Study.雾化多黏菌素与持续循环阿奇霉素用于因……导致慢性支气管感染的重度慢性阻塞性肺疾病患者:一项回顾性队列研究
Int J Chron Obstruct Pulmon Dis. 2019 Oct 17;14:2365-2373. doi: 10.2147/COPD.S209513. eCollection 2019.
10
Inhaled corticosteroids and risk of pneumonia in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials.吸入性皮质类固醇与慢性阻塞性肺疾病患者肺炎风险:一项随机对照试验的荟萃分析。
Int Immunopharmacol. 2019 Dec;77:105950. doi: 10.1016/j.intimp.2019.105950. Epub 2019 Oct 17.